Curaleaf (OTCMKTS:CURLF) Trading Down 5.5% – Should You Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s stock price traded down 5.5% during mid-day trading on Tuesday . The company traded as low as $3.09 and last traded at $3.1370. 842,105 shares changed hands during mid-day trading, a decline of 21% from the average session volume of 1,068,583 shares. The stock had previously closed at $3.32.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three equities research analysts have rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Strong Buy”.

Curaleaf Stock Performance

The firm has a market cap of $2.31 billion, a price-to-earnings ratio of -25.46 and a beta of 1.58. The company has a quick ratio of 0.74, a current ratio of 1.56 and a debt-to-equity ratio of 1.05. The stock has a fifty day moving average price of $2.89 and a 200-day moving average price of $2.66.

Curaleaf (OTCMKTS:CURLF) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.17. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The firm had revenue of $324.23 million for the quarter, compared to analyst estimates of $316.62 million. On average, analysts expect that Curaleaf Holdings, Inc. will post -0.1 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.